TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive In Brief: Deisseroth Leaves M.D. Anderson To Head Yale’s Oncology, Gene Therapy Programs September 15, 1995
TCL Archive Senate Subcommittee Adds $98 Million to NCI’s FY 1984 Budget, Assuring Substantial Increase September 30, 1983
